A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis

A real-world clinical validation for AI-based MRI monitoring in multiple sclerosis

Abstract Modern management of MS targets No Evidence of Disease Activity (NEDA): no clinical relapses, no magnetic resonance imaging (MRI) disease activity and no disability worsening. While MRI is the principal tool available to neurologists for monitoring clinically silent MS disease activity and,...

Full description

Bibliographic Details
Main Authors: Michael Barnett, Dongang Wang, Heidi Beadnall, Antje Bischof, David Brunacci, Helmut Butzkueven, J. William L. Brown, Mariano Cabezas, Tilak Das, Tej Dugal, Daniel Guilfoyle, Alexander Klistorner, Stephen Krieger, Kain Kyle, Linda Ly, Lynette Masters, Andy Shieh, Zihao Tang, Anneke van der Walt, Kayla Ward, Heinz Wiendl, Geng Zhan, Robert Zivadinov, Yael Barnett, Chenyu Wang
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:npj Digital Medicine
Online Access:https://doi.org/10.1038/s41746-023-00940-6

Internet

https://doi.org/10.1038/s41746-023-00940-6

Similar Items